by the use of different growth substrates that are metabolized to common intermediates. For example, benzoate and p-hydroxybenzoate are both metabolized to the enol-lactone of fi-ketoadipate in P. putida (21) , and, as shown by Ornston et al. (22) , strains defective in genes for cis,cis-muconate cycloisomerase and muconolactone isomerase were readily selected by using benzoate in the lytic cycle and p-hydroxybenzoate for the recovery cycle.
Positive enrichments of mutants defective in catabolic pathways have been achieved by causing wild-type cells to form a toxic metabolite. This is usually accomplished in one of two ways: (i) a prior genetic alternation causes the cell to form a normal metabolite from the substrate in concentrations that are toxic (13, 16, 17, 19, 26) ; or (ii) the cells are exposed to a substrate analog that can be partially metabolized to an intermediate analog which is toxic (1-3, 9, 19, 30) . Some of the substrate analogs that have been used contain fluorine. Thus fluoroacetamide and fluoroacetate were used successfully to enrich tida JT811 and have shown that chloro, bromo, and iodo analogs ofp-cymene or its metabolites can cause the enrichment of mutants defective in p-cymene catabolism (30) . In this paper we describe a procedure that has allowed very high and selective enrichments of pseudomonad strains defective in one or more of the genes required for the catabolism of eight aromatic compounds by pathways already biochemically well characterized. A possible ecological consequence of enrichments of this sort as they may occur in nature is discussed.
MATERIALS AND METHODS Bacterial strains. Table 1 lists the relevant phenotypes, genotypes, or both of the bacterial strains used. All are strains of P. putida except AC548, which is Escherichia coli K-12, and JT701, which is Pseudomonas fluorescens. Details of propagation and maintenance are provided in the references in Table   1 .
Chemicals and media. Sources of chemicals and media available from commercial sources have been described (10, 11, 29, 30) , including minimal medium composition for the enrichments (30 Rationale for selective enrichments. In previous experimental protocols used for mutant enrichments with fluorinated analogs, the toxic metabolite (presumed to be fluorocitrate, but see reference 5) needed to be only biostatic to the wild type and not necessarily biocidal in its effect, whereas defective mutants continued to grow on unrelated carbon sources. This procedure was probably necessary for the enrichments, since in many microorganisms it would be expected that fluorocitrate may arrest growth without necessarily killing the cells.
In our protocol the successful selective enrichments of defective mutants depend on the mutants surviving the exposure to a halogenated analog and being rescued on unrelated media while the wild type dies. This protocol, like that described above, selects for mutants defective in the formation of potentially toxic analogs. The toxic analog metabolites need to exert their effects only in cells competent in the catabolic pathway; that is, they must have little or no effect on neighbors if they are excreted into the medium.
Experimental protocol for selective enrichments. The basic experimental protocol we employed was as follows. An inoculum (2% by volume) of nonmutagenized, nutrient broth-grown bacteria was introduced into a simple minimal medium, usually 5 or 10 ml, with the required auxetrophic supplement. The natural substrate was always provided in the medium to increase the chances of co-oxidation of the halogenated analogs since substrate analogs may be unable to induce the pathway enzymes. Aromatic carbon sources were provided at 2.5 mM; for volatile compounds they were provided as a vapor from a reservoir contained within small free-standing culture tubes. Halogenated analogs were used at 2.5 mM for experiments with p-cymene-utilizing organisms and at one or more of the concentrations of 1 (30) .
Enrichments of mutants defective in other hydrocarbon degradative pathways have been achieved. Prototrophic strains of P. putida strain U that harbored either TOL (20, 31, 32) or a cointegrate, RP1-TOL (8), plasmids were incubated in the presence of 3-fluoro-p-toluate, and this provided significant enrichment of strains unable to grow at the expense ofp-toluate ( Table 2 ). All negative strains isolated from the TOL strain appeared to have been cured of some TOL functions since none of 50 clones tested gave revertants on p-toluate. All of 268 clones rescued from the RP1-TOL host, unable to utilize p-toluate, retained Cb and Km/Nm antibiotic resistance markers. However, they failed to regain the Tc marker of the RP1 plasmid, which was lost on insertion of TOL into RP1. This is similar to the mode of segregation of this RP1-TOL cointegrate plasmid that has been reported (8) .
Three auxotrophic, plasmid-bearing, salicylate-utilizing strains (7, 12) were tested for their sensitivity to the presence of 5-fluorosalicylate. Pathway for the metabolism ofp-substituted toluenes and benzoates with "2,3-dihydroxybenzoates" as ring-cleavage substrates. Enzymes: (1)p-Cymene hydroxylase; (2) p-isopropylbenzyl alcohol dehydrogenase; (3) p-isopropylbenzaldehyde dehydrogenase; (4) p-cumate 2,3-dioxygenase; (5) "dihydrodiol" dehydrogenase; (6) 2,3-dihydroxy-p-cumate 3,4-dioxygenase; (7) "ring-cleavage product" decarboxylase; (8) hydrolase; (9) hydratase; and (10) aldolase. Symbols I to X refer to the chemical intermediates in the degradative sequence. XI, Pyruvate; XII, acetaldehyde. A, B, C through N refer to the proposed cistrons which encode the enzymes of the the degradative sequence (30) . The gene encoding p-hydroxybenzoate hydroxylase has been shown to reside on the chromosome in strains of P. putida and P. aeruginosa (21, 28) . p-Hydroxybenzoate hydroxylasenegative mutants of P. putida U have been isolated after exposure to 3-fluoro-4-hydroxybenzoate ( P. putida U grows at the expense of phenol and the isomers of cresol by meta cleavage of the appropriate catechol fonned, following mono-hydroxylation (Fig. 2) . m-Toluate is also a growth substrate which recruits the "benzoateoxidase system" to form 3-methylcatechol, which is then metabolized by the same metacleavage enzymes (Ribbons and Wigmore, unpublished data). The enzymes which determine these reaction sequences appear to be encoded by chromosomal genes. Mutants were readily isolated that were defective in enzymes of the phenol pathway after exposure to 3-fluorophenol, 4-fluorophenol, and 3-chlorophenol (Table 3). Compounds that failed to enrich for mutants included 4-fluoro-o-cresol, 3-chlorophenol, 3,5-dichlorocatechol, 4-chlorophenol, and 2,4-dibromophenol. Mutants in this experiment were initially recognized by their failure to grow at the expense of one or more of the five growth substrates that are metabolized by the metacleavage pathway (Table 1, Fig. 2 ). Tentative characterization of these mutants was made by studying the growth spectra, by spot testing with 4-methylcatechol for the detection of catechol 2,3-oxygenase activity, and by observing product accumulation when mutants were grown at the expense of glutamate in the presence of each of the aromatic substrates (Table 4) . Mutants of phenotype groups III, IV, and V have been isolated previously after mutagenesis and by using different enrichment procedures (29) .
In all of these studies a variety of criteria have been used to demonstrate that catabolically defective survivors are derived from the parent and do not represent contamination; the criteria used, where applicable, include colonial morphology and pigmentation, retention of auxotrophic markers and relatively novel catabolic functions (e.g., p-cymene utilization in the case of p-anisate-negative P. putida JT101), the retention of specifically inducible enzymes of reaction sequences in mutant strains, and the reversion of mutant lesions. These data will be presented as separate communications. 
DISCUSSION
Halogenated compounds in general biodegrade more slowly than related non-halogenated analogs. Several biochemical considerations have been invoked by this resistance to microbial decomposition. Hughes (14) suggested that 5-fluoronicotinate failed to support growth of P. fluorescens because it is a poor inducer and inhibits nicotinate induction of the nicotinate pathway enzymes. Later, Behrman and Stanier (4) suggested that 5-fluoronicotinate fails to support the growth of nicotinate-degrading pseudomonads, despite its extensive oxidation, because a lethal metabolite analog is formed. Sir Rudolph Peters coined the expression "lethal synthesis" to describe the toxicity of fluoroacetate (24) , which exerts its toxicity in animals after metabolism to fluorocitrate, a potent inhibitor of aconitase. Peters explicitly restricted the term to enzyme-mediated conversion(s) to toxic compounds as distinguished from the inhibitors, e.g., the trivalent arsenicals, non-enzymatically formed from arsephenamines. The frequency of lethal syntheses among transformations of halogenated compounds remains to be determined, although this strategy has been used for selective herbicide action (27) . Also, halogenated compounds have been used as "suicide-substrates" to probe the mechanism of enzyme action (18, 25) .
Positive enrichments of mutants defective in catabolic pathways have been achieved by exposing wild-type cells to fluorinated analogs of the growth substrates or their metabolic intermediates (1) (2) (3) 9) . Mutants defective in p-cymene catabolism in P. putida are readily obtained after incubation with chloro, bromo, and iodo analogs (30; (Table   4 ).
Although we have not provided new principles for the selective enrichment ofmutants defective in catabolic pathways, it is worth noting again Apirion's discussion (1) of a general system for the automatic selection of auxotrophs from prototrophs and vice versa (in this context auxotroph had its wider meaning rather than a specific nutritional requirement to satisfy biosynthesis). There are technical and pragmatic features of the systems we have studied that have probably contributed to the successful enrichment of the mutants. The ready availability of a variety of halogenated analogs from commercial sources prompted rapid experimentation (one analog, 3-fluoro-p-anisate, was easily synthesized, and another, 3-fluoro-4-hydroxybenzoate, was a gift from P. J. Chapman). Furthermore, in all of the pathways studied most of the reactions involved are free of stereochemical constraints imposed by asymmetric centers possessed by most substrates and metabolites of central metabolism.
At present little is known about the identity of the intermediates thought to be lethal and responsible for the enrichment of the catabolically defective strains. Preliminary indications are that some halogenated ring-cleavage substrates or products may be the responsible agents. This is based on the known toxicity of some halogenated catechols and on the chemical reactivity of acylhalides that are conceivably produced by meta cleavage of, for example, 2,3-dihydroxy-4-iodobenzoate between carbon atoms 3 and 4 (reaction 6 in the p-cymene pathway, Fig. 1 ) or 3-fluorocatechol between carbon atoms 2 and 3 (reaction 1, Fig. 2 ). It is significant that mutants defective in thep-cymene enzymes below reaction 6 ( Fig. 1) have not been isolated with 4-halobenzoates as the substrate analogs (30) . Similarly, mutants blocked below ringcleavage in the phenol (cresols) pathway (Fig. 2) have not been obtained in P. putida U after enrichment with 3-fluorophenol (Table 4) , although they have been obtained after penicillin enrichments in both systems (11, 29) .
Our observations have a number of implications and applications. The procedure provides a potent, rapid, and expedient method for the isolation of spontaneous mutants and for the elimination of catabolic functions of some degradative plasmids, since the enrichments described are specific. This may be of use when degradative plasmids are used as vectors to introduce transposons into bacterial strains as a means to isolate transposon-induced mutations.
Defective mutant strains in the catabolic pathways described here have been readily obtained without prior known mutagenic treatment, and thus these strains may be considered to be isogenic in other respects with the parent. The selective apparent toxicity could also be adapted to the enrichment of minority bacterial species from a natural environment when overgrowth by pseudomonads is likely to hamper their isolation. The potential for lethal syntheses should be considered when the biodegradability of halogenated compounds is being assessed by techniques such as co-oxidation (23), since the chemical or biochemical transformations of synthetic substrate analogs to toxic intermediates may contribute to the recalcitrance of many halogenated compounds and even to the turnover in nature of the natural substrate. Experiments with soil perfusions using mixtures of p-toluate and 3-fluoro-p-toluate as sources of carbon have shown that 3-fluoro-p-toluate can prevent enrichment ofp-toluate-utilizing strains over a period of 3 months with little or no utilization of either compound; in the absence of the analog, p-toluate-utilizing bacteria appear in 2 to 3 days with complete consumption of the carbon source (C. J. Heath, and D. W. Ribbons, unpublished data).
